Clinical evaluation of cisplatin sensitivity of germline polymorphisms in neoadjuvant chemotherapy for urothelial cancer

PH O'Donnell, S Alanee, KL Stratton… - Clinical genitourinary …, 2016 - Elsevier
Background Level 1 evidence has demonstrated increased overall survival with cisplatin-
based neoadjuvant chemotherapy for patients with muscle-invasive urothelial cancer …
被引用次数：8 相关文章

Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer

PH O'Donnell, S Alanee… - Clinical …, 2016 - clinical-genitourinary-cancer.com
Background Level 1 evidence has demonstrated increased overall survival with cisplatin-
based neoadjuvant chemotherapy for patients with muscle-invasive urothelial cancer …
[PDF] researchgate.net

[PDF][PDF] Clinical Evaluation of Cisplatin Sensitivity Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer

PH O'Donnell, S Alanee, KL Stratton… - Clin Genitourin …, 2016 - researchgate.net
BACKGROUND—Level 1 evidence demonstrates increased overall survival with cisplatin-
based neoadjuvant chemotherapy for patients with muscle-invasive urothelial cancer …

Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer

PH O'Donnell, S Alanee, KL Stratton… - Clinical …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Level 1 evidence has demonstrated increased overall survival with cisplatin-
based neoadjuvant chemotherapy for patients with muscle-invasive urothelial cancer …
[HTML] nih.gov

[HTML][HTML] Clinical Evaluation of Cisplatin Sensitivity Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer

PH O'Donnell, S Alanee, KL Stratton… - Clinical genitourinary …, 2016 - ncbi.nlm.nih.gov
BACKGROUND Level 1 evidence demonstrates increased overall survival with cisplatin-
based neoadjuvant chemotherapy for patients with muscle-invasive urothelial cancer …

Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer.

PH O'Donnell, S Alanee, KL Stratton… - Clinical Genitourinary …, 2016 - europepmc.org
Background Level 1 evidence has demonstrated increased overall survival with cisplatin-
based neoadjuvant chemotherapy for patients with muscle-invasive urothelial cancer …

Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer

PH O'Donnell, S Alanee, KL Stratton… - Clinical Genitourinary …, 2016 - infona.pl
Level 1 evidence has demonstrated increased overall survival with cisplatin-based
neoadjuvant chemotherapy for patients with muscle-invasive urothelial cancer. Usage …

Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer.

PH O'Donnell, S Alanee, KL Stratton… - Clinical Genitourinary …, 2016 - europepmc.org
Background Level 1 evidence has demonstrated increased overall survival with cisplatin-
based neoadjuvant chemotherapy for patients with muscle-invasive urothelial cancer …

[引用][C] Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer

PH O'Donnell, S Alanee, KL Stratton…